LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 542

Search options

  1. Article ; Online: The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer's Disease: Suggestions from a Case Report.

    Lombardi, Gemma / Berti, Valentina / Ginestroni, Andrea / Nacmias, Benedetta / Sorbi, Sandro

    Journal of Alzheimer's disease reports

    2024  Volume 8, Issue 1, Page(s) 281–288

    Abstract: Amyloid-β deposition is the pathological hallmark of both cerebral amyloid angiopathy and Alzheimer's disease dementia, clinical conditions that can share cognitive decline and positive Amyloid-PET scan. A case is reported involving an 82-year-old ... ...

    Abstract Amyloid-β deposition is the pathological hallmark of both cerebral amyloid angiopathy and Alzheimer's disease dementia, clinical conditions that can share cognitive decline and positive Amyloid-PET scan. A case is reported involving an 82-year-old Italian female who presented initially a memory deficit, later transient focal neurologic episodes, and finally two symptomatic lobar intracerebral hemorrhages. In light of these events, MRI and PET imaging findings, acquired before cerebral hemorrhages, are reconsidered and discussed, highlighting the utility of Amyloid-PET in supporting an
    Language English
    Publishing date 2024-02-16
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2542-4823
    ISSN (online) 2542-4823
    DOI 10.3233/ADR-230183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The complexity of Alzheimer's disease: an evolving puzzle.

    Ferrari, Camilla / Sorbi, Sandro

    Physiological reviews

    2021  Volume 101, Issue 3, Page(s) 1047–1081

    Abstract: The history of Alzheimer's disease (AD) started in 1907, but we needed to wait until the end of the century to identify the components of pathological hallmarks and genetic subtypes and to formulate the first pathogenic hypothesis. Thanks to biomarkers ... ...

    Abstract The history of Alzheimer's disease (AD) started in 1907, but we needed to wait until the end of the century to identify the components of pathological hallmarks and genetic subtypes and to formulate the first pathogenic hypothesis. Thanks to biomarkers and new technologies, the concept of AD then rapidly changed from a static view of an amnestic dementia of the presenium to a biological entity that could be clinically manifested as normal cognition or dementia of different types. What is clearly emerging from studies is that AD is heterogeneous in each aspect, such as amyloid composition, tau distribution, relation between amyloid and tau, clinical symptoms, and genetic background, and thus it is probably impossible to explain AD with a single pathological process. The scientific approach to AD suffers from chronological mismatches between clinical, pathological, and technological data, causing difficulty in conceiving diagnostic gold standards and in creating models for drug discovery and screening. A recent mathematical computer-based approach offers the opportunity to study AD in real life and to provide a new point of view and the final missing pieces of the AD puzzle.
    MeSH term(s) Alzheimer Disease/diagnosis ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Amyloid beta-Peptides/metabolism ; Biomarkers/metabolism ; Brain/metabolism ; Brain/pathology ; Humans ; Peptide Fragments/metabolism ; Plaque, Amyloid/diagnosis ; Plaque, Amyloid/metabolism ; Plaque, Amyloid/pathology
    Chemical Substances Amyloid beta-Peptides ; Biomarkers ; Peptide Fragments
    Language English
    Publishing date 2021-01-21
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 209902-0
    ISSN 1522-1210 ; 0031-9333
    ISSN (online) 1522-1210
    ISSN 0031-9333
    DOI 10.1152/physrev.00015.2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Creutzfeldt-Jakob Disease in a Patient with Previous COVID-19 Infection: "The Virus Caused the Derangement in My Brain".

    Leccese, Deborah / Cornacchini, Sara / Nacmias, Benedetta / Sorbi, Sandro / Bessi, Valentina

    Journal of Alzheimer's disease reports

    2023  Volume 7, Issue 1, Page(s) 129–134

    Abstract: Recent studies have speculated a link between Creutzfeldt-Jakob disease (CJD) and COVID-19, following the description of CJD cases after COVID-19 infection. We report the case of a 71-year-old female patient who developed neuropsychiatric and ... ...

    Abstract Recent studies have speculated a link between Creutzfeldt-Jakob disease (CJD) and COVID-19, following the description of CJD cases after COVID-19 infection. We report the case of a 71-year-old female patient who developed neuropsychiatric and neurological symptoms after COVID-19 infection and was later diagnosed with CJD. Cerebrospinal fluid (CSF) total tau levels were slightly increased. She resulted prion protein gene (PRNP) M129V heterozygous. We aim to emphasize the role of the polymorphism at codon 129 of PRNP gene on the clinical phenotype and duration of CJD, and the CSF total tau levels that likely correlate with the rate of disease progression.
    Language English
    Publishing date 2023-02-14
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2542-4823
    ISSN (online) 2542-4823
    DOI 10.3233/ADR-220095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Understanding the role of self-attention in a Transformer model for the discrimination of SCD from MCI using resting-state EEG.

    Sibilano, Elena / Buongiorno, Domenico / Lassi, Michael / Grippo, Antonello / Bessi, Valentina / Sorbi, Sandro / Mazzoni, Alberto / Bevilacqua, Vitoantonio / Brunetti, Antonio

    IEEE journal of biomedical and health informatics

    2024  Volume PP

    Abstract: The identification of EEG biomarkers to discriminate Subjective Cognitive Decline (SCD) from Mild Cognitive Impairment (MCI) conditions is a complex task which requires great clinical effort and expertise. We exploit the self-attention component of the ... ...

    Abstract The identification of EEG biomarkers to discriminate Subjective Cognitive Decline (SCD) from Mild Cognitive Impairment (MCI) conditions is a complex task which requires great clinical effort and expertise. We exploit the self-attention component of the Transformer architecture to obtain physiological explanations of the model's decisions in the discrimination of 56 SCD and 45 MCI patients using resting-state EEG. Specifically, an interpretability workflow leveraging attention scores and time-frequency analysis of EEG epochs through Continuous Wavelet Transform is proposed. In the classification framework, models are trained and validated with 5-fold cross-validation and evaluated on a test set obtained by selecting 20% of the total subjects. Ablation studies and hyperparameter tuning tests are conducted to identify the optimal model configuration. Results show that the best performing model, which achieves acceptable results both on epochs' and patients' classification, is capable of finding specific EEG patterns that highlight changes in the brain activity between the two conditions. We demonstrate the potential of attention weights as tools to guide experts in understanding which disease-relevant EEG features could be discriminative of SCD and MCI.
    Language English
    Publishing date 2024-04-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2695320-1
    ISSN 2168-2208 ; 2168-2194
    ISSN (online) 2168-2208
    ISSN 2168-2194
    DOI 10.1109/JBHI.2024.3390606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.

    Ingannato, Assunta / Bagnoli, Silvia / Mazzeo, Salvatore / Giacomucci, Giulia / Bessi, Valentina / Ferrari, Camilla / Sorbi, Sandro / Nacmias, Benedetta

    Frontiers in endocrinology

    2024  Volume 15, Page(s) 1375302

    Abstract: Background: Plasma biomarkers are preferable to invasive and expensive diagnostic tools, such as neuroimaging and lumbar puncture that are gold standard in the clinical management of Alzheimer's Disease (AD). Here, we investigated plasma Glial ... ...

    Abstract Background: Plasma biomarkers are preferable to invasive and expensive diagnostic tools, such as neuroimaging and lumbar puncture that are gold standard in the clinical management of Alzheimer's Disease (AD). Here, we investigated plasma Glial Fibrillary Acidic Protein (GFAP), Neurofilament Light Chain (NfL) and Phosphorylated-tau-181 (pTau 181) in AD and in its early stages: Subjective cognitive decline (SCD) and Mild cognitive impairment (MCI).
    Material and methods: This study included 152 patients (42 SCD, 74 MCI and 36 AD). All patients underwent comprehensive clinical and neurological assessment. Blood samples were collected for Apolipoprotein E (APOE) genotyping and plasma biomarker (GFAP, NfL, and pTau 181) measurements. Forty-three patients (7 SCD, 27 MCI, and 9 AD) underwent a follow-up (FU) visit after 2 years, and a second plasma sample was collected. Plasma biomarker levels were detected using the Simoa SR-X technology (Quanterix Corp.). Statistical analysis was performed using SPSS software version 28 (IBM SPSS Statistics). Statistical significance was set at p < 0.05.
    Results: GFAP, NfL and pTau 181 levels in plasma were lower in SCD and MCI than in AD patients. In particular, plasma GFAP levels were statistically significant different between SCD and AD (
    Discussion and conclusions: Plasma GFAP, NfL and pTau 181 are promising biomarkers in the diagnosis of the prodromic stages and prognosis of dementia.
    MeSH term(s) Humans ; Glial Fibrillary Acidic Protein/blood ; Female ; Male ; Neurofilament Proteins/blood ; tau Proteins/blood ; Aged ; Biomarkers/blood ; Cognitive Dysfunction/blood ; Cognitive Dysfunction/diagnosis ; Alzheimer Disease/blood ; Alzheimer Disease/diagnosis ; Middle Aged ; Phosphorylation ; Dementia/blood ; Dementia/diagnosis ; Apolipoproteins E/blood ; Apolipoproteins E/genetics ; Aged, 80 and over ; Follow-Up Studies
    Chemical Substances Glial Fibrillary Acidic Protein ; Neurofilament Proteins ; tau Proteins ; Biomarkers ; neurofilament protein L ; GFAP protein, human ; Apolipoproteins E ; MAPT protein, human
    Language English
    Publishing date 2024-04-09
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2024.1375302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Huntington's Disease Gene in an Italian Cohort of Patients with Bipolar Disorder.

    Ferrari, Camilla / Capacci, Elena / Bagnoli, Silvia / Ingannato, Assunta / Sorbi, Sandro / Nacmias, Benedetta

    Genes

    2023  Volume 14, Issue 9

    Abstract: Background and objectives: Huntington's disease (HD) is characterized by motor, cognitive and psychiatric manifestations and caused by an expansion of CAG repeats over 35 triplets on the huntingtin (: Methods: We assessed the : Results: No patient ...

    Abstract Background and objectives: Huntington's disease (HD) is characterized by motor, cognitive and psychiatric manifestations and caused by an expansion of CAG repeats over 35 triplets on the huntingtin (
    Methods: We assessed the
    Results: No patient was found to be a carrier of the pathological
    Conclusion: The pathological
    MeSH term(s) Humans ; Bipolar Disorder/genetics ; Huntington Disease/genetics ; Alleles ; Genotype ; Family
    Language English
    Publishing date 2023-08-25
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2527218-4
    ISSN 2073-4425 ; 2073-4425
    ISSN (online) 2073-4425
    ISSN 2073-4425
    DOI 10.3390/genes14091681
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Beta-amyloid immunisation in Alzheimer's disease.

    Sorbi, S

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

    2005  Volume 26 Suppl 1, Page(s) S5

    MeSH term(s) Alzheimer Disease/immunology ; Alzheimer Disease/therapy ; Amyloid beta-Peptides/immunology ; Humans ; Immunotherapy/methods ; Lymphocyte Activation ; Peptide Fragments/immunology
    Chemical Substances Amyloid beta-Peptides ; Peptide Fragments ; amyloid beta-protein (1-42)
    Language English
    Publishing date 2005-05
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2016546-8
    ISSN 1590-3478 ; 1590-1874
    ISSN (online) 1590-3478
    ISSN 1590-1874
    DOI 10.1007/s10072-005-0388-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Intermediate alleles of HTT: A new pathway in longevity.

    Ingannato, Assunta / Bagnoli, Silvia / Bessi, Valentina / Ferrari, Camilla / Mazzeo, Salvatore / Sorbi, Sandro / Nacmias, Benedetta

    Journal of the neurological sciences

    2022  Volume 438, Page(s) 120274

    Abstract: Centenarians are the best example of successful aging, reaching extreme longevity escaping age-related diseases. Genome sequencing studies provided evidence for genetic factors linked to heathy long life, including genes related to age-dependent diseases. ...

    Abstract Centenarians are the best example of successful aging, reaching extreme longevity escaping age-related diseases. Genome sequencing studies provided evidence for genetic factors linked to heathy long life, including genes related to age-dependent diseases. HTT (Huntingtin) gene is linked to Huntington's Disease, but also associated to longevity in capuchins and mice. HTT Intermediate alleles (IAs) are defined as CAG repeat expansion between 27 and 35. According to recent data IAs might increase Alzheimer's Disease risk, but also might have a neuroprotective effect and can confer an advantage in brain development. Here, we investigated, for the first time, the possible implication of HTT IAs in extreme longevity and their possible association in cognitive decline. We analysed the distribution of IAs in Italian Centenarians (n = 143) and compared with pathological controls with cognitive decline (n = 232, including 80 Alzheimer's Disease, 78 Frontotemporal Dementia and 74 Subjective Cognitive Decline patients) and healthy controls (n = 104). Our data show a statistically significant higher frequency of IAs in Centenarians with respect to pathological controls with cognitive decline (p = .031; OR = 2.3097 95% CI 1.0591 to 5.0371), with a percentage of 11.2 respect to 5.4 respectively. The highest presence of IAs in Centenarians confirms and extends in humans a possible implication of HTT gene in exceptional lifespan and in brain development with a neuroprotective effect.
    MeSH term(s) Aged, 80 and over ; Alleles ; Alzheimer Disease/genetics ; Animals ; Humans ; Huntingtin Protein/genetics ; Huntington Disease/genetics ; Longevity/genetics ; Mice
    Chemical Substances HTT protein, human ; Huntingtin Protein
    Language English
    Publishing date 2022-05-04
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80160-4
    ISSN 1878-5883 ; 0022-510X ; 0374-8642
    ISSN (online) 1878-5883
    ISSN 0022-510X ; 0374-8642
    DOI 10.1016/j.jns.2022.120274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.

    Ingannato, Assunta / Bessi, Valentina / Chiari, Annalisa / Salvatori, Davide / Bagnoli, Silvia / Bedin, Roberta / Ferrari, Camilla / Sorbi, Sandro / Nacmias, Benedetta

    Journal of Alzheimer's disease : JAD

    2023  Volume 96, Issue 2, Page(s) 767–775

    Abstract: Background: Progranulin protein (GRN) is a growth factor, encoded by the GRN (Granulin precursor) gene, involved in several functions including inflammation, wound repair, signal transduction, proliferation, and tumorigenesis. Mutations in GRN gene are ... ...

    Abstract Background: Progranulin protein (GRN) is a growth factor, encoded by the GRN (Granulin precursor) gene, involved in several functions including inflammation, wound repair, signal transduction, proliferation, and tumorigenesis. Mutations in GRN gene are usually the genetic etiology of frontotemporal dementia (FTD), but different studies reported GRN mutations in Alzheimer 's disease (AD) patients.
    Objective: Here, we analyzed FTD linked gene GRN in 23 patients with a clinical diagnosis of AD and a family history of AD (FAD), not carrying mutations in AD candidate genes (PSEN 1, PSEN 2, and APP). In addition, Microtubule-associated protein tau (MAPT) gene was studied too. All patients underwent an extensive neuropsychological battery.
    Methods: Genetic analyses were performed thought PCR assay and sequencing. Variants were annotated with ANNOVAR and allele frequency was checked on population databases. In silico prediction tools were consulted to check nonsynonymous variants and their effect on protein function and structure. The clinical data were retrospectively collected from medical records.
    Results: Genetic screening of MAPT and GRN in 23 FAD patients highlighted two rare different variants in two probands (2/23 = 8,7%) located in GRN gene: R433W (p.Arg433Trp) and C521Y (p.Cys521Tyr). The R433W and C521Y are variants with uncertain significant, that are predicted to affect GRN protein structure and function, with a possible damaging effect.
    Conclusions: Our data provide evidence of the importance of GRN genetic analysis also in the study of familial AD.
    MeSH term(s) Humans ; Alzheimer Disease/genetics ; Frontotemporal Dementia/genetics ; Retrospective Studies ; Intercellular Signaling Peptides and Proteins/genetics ; Progranulins/genetics ; Mutation/genetics
    Chemical Substances Intercellular Signaling Peptides and Proteins ; Progranulins ; GRN protein, human
    Language English
    Publishing date 2023-10-29
    Publishing country Netherlands
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management.

    Stocchi, Fabrizio / Angelo Antonini / Barone, Paolo / Bellelli, Giuseppe / Fagiolini, Andrea / Ferini Strambi, Luigi / Sorbi, Sandro / Padovani, Alessandro

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

    2023  Volume 44, Issue 9, Page(s) 3123–3131

    Abstract: Background: Depression is a prodromic and a frequent non-motor symptom of Parkinson's disease, associated to reduced quality of life and poor outcomes. The diagnosis of depression in parkinsonian patients represents a challenge due to the overlapping of ...

    Abstract Background: Depression is a prodromic and a frequent non-motor symptom of Parkinson's disease, associated to reduced quality of life and poor outcomes. The diagnosis of depression in parkinsonian patients represents a challenge due to the overlapping of symptoms typical of the two conditions.
    Methods: A Delphi panel survey was performed to reach a consensus amongst different Italian specialists on four main topics: the neuropathological correlates of depression, main clinical aspects, diagnosis, and management of depression in Parkinson's disease.
    Results and conclusion: Experts have recognized that depression is an established risk factor of PD and that its anatomic substrate is related to the neuropathological abnormalities typical of the disease. Multimodal and SSRI antidepressant have been confirmed as a valid therapeutic option in the treatment of depression in PD. Tolerability, safety profile, and potential efficacy on broad spectrum of symptoms of depression including cognitive symptoms and anhedonia should be considered when selecting an antidepressant and the choice should be tailored on the patients' characteristics.
    MeSH term(s) Humans ; Parkinson Disease/complications ; Parkinson Disease/diagnosis ; Parkinson Disease/therapy ; Depression/diagnosis ; Depression/etiology ; Depression/therapy ; Consensus ; Quality of Life ; Delphi Technique ; Antidepressive Agents/therapeutic use
    Chemical Substances Antidepressive Agents
    Language English
    Publishing date 2023-04-27
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2016546-8
    ISSN 1590-3478 ; 1590-1874
    ISSN (online) 1590-3478
    ISSN 1590-1874
    DOI 10.1007/s10072-023-06740-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top